BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23138923)

  • 1. Regulatory assessment of reproductive toxicology data.
    Davidson E
    Methods Mol Biol; 2013; 947():489-516. PubMed ID: 23138923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Toxicology of reproduction: predictive value of experimental models. Round Table No 1 at Giens XIII].
    Guittin P; Soubrié C; Autret E; Boutemy C; Eléfant E; Jacqz-Aigrain E; Le Bigot JF; Marmor D; Marzin D; Pallardy M; Roux C; Saint Salvi B; Siou G; Soufir JC; Spézia F; Stadler J
    Therapie; 1998; 53(4):355-63. PubMed ID: 9806005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nonclinical fertility study design for pharmaceuticals.
    Lerman SA; Hew KW; Stewart J; Stump DG; Wise LD
    Birth Defects Res B Dev Reprod Toxicol; 2009 Dec; 86(6):429-36. PubMed ID: 20025039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Considerations in assessing the developmental and reproductive toxicity potential of biopharmaceuticals.
    Martin PL; Breslin W; Rocca M; Wright D; Cavagnaro J
    Birth Defects Res B Dev Reprod Toxicol; 2009 Jun; 86(3):176-203. PubMed ID: 19462404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview: developmental toxicology: new directions.
    Shuey D; Kim JH
    Birth Defects Res B Dev Reprod Toxicol; 2011 Oct; 92(5):381-3. PubMed ID: 21770024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International Conference on Harmonisation; Guidance on M3(R2) Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2010 Jan; 75(13):3471-2. PubMed ID: 20349552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reproductive toxicants have a threshold of adversity.
    Piersma AH; Hernandez LG; van Benthem J; Muller JJ; van Leeuwen FX; Vermeire TG; van Raaij MT
    Crit Rev Toxicol; 2011 Jul; 41(6):545-54. PubMed ID: 21609253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International Conference on Harmonisation; Guidance on E16 Biomarkers Related to Drug or Biotechnology Product Development: Context, Structure, and Format of Qualification Submissions; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2011 Aug; 76(155):49773-4. PubMed ID: 21834216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exposure-triggered reproductive toxicity testing under the REACH legislation: a proposal to define significant/relevant exposure.
    Bernauer U; Heinemeyer G; Heinrich-Hirsch B; Ulbrich B; Gundert-Remy U
    Toxicol Lett; 2008 Jan; 176(1):68-76. PubMed ID: 18068317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of the toxicology, human exposure and safety assessment for bisphenol A diglycidylether (BADGE).
    Poole A; van Herwijnen P; Weideli H; Thomas MC; Ransbotyn G; Vance C
    Food Addit Contam; 2004 Sep; 21(9):905-19. PubMed ID: 15666984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reproductive toxicology guidelines: comparison and application.
    Beltrame D; Mazué G
    Ann Ist Super Sanita; 1993; 29(1):3-14. PubMed ID: 8129269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Developmental and reproductive toxicology: interest and interpretation].
    Stadler J
    Therapie; 2014; 69(1):25-30. PubMed ID: 24698185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety evaluation and risk assessment of the herbicide Roundup and its active ingredient, glyphosate, for humans.
    Williams GM; Kroes R; Munro IC
    Regul Toxicol Pharmacol; 2000 Apr; 31(2 Pt 1):117-65. PubMed ID: 10854122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of in vitro cell transformation assays in regulatory toxicology for pharmaceuticals, chemicals, food products and cosmetics.
    Vanparys P; Corvi R; Aardema MJ; Gribaldo L; Hayashi M; Hoffmann S; Schechtman L
    Mutat Res; 2012 Apr; 744(1):111-6. PubMed ID: 22342612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of the mode of action framework for mutagenic carcinogens case study: Cyclophosphamide.
    McCarroll N; Keshava N; Cimino M; Chu M; Dearfield K; Keshava C; Kligerman A; Owen R; Protzel A; Putzrath R; Schoeny R
    Environ Mol Mutagen; 2008 Mar; 49(2):117-31. PubMed ID: 18240158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human and laboratory animal test systems available for detection of reproductive failure.
    Manson JM
    Prev Med; 1978 Sep; 7(3):322-31. PubMed ID: 733731
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of genetic toxicology information for risk assessment.
    Dearfield KL; Moore MM
    Environ Mol Mutagen; 2005 Dec; 46(4):236-45. PubMed ID: 16258925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An overview of developmental and reproductive toxicity risk assessment in China.
    Wang H; Wang Q; Liao M
    Birth Defects Res B Dev Reprod Toxicol; 2010 Feb; 89(1):2-8. PubMed ID: 20077514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developmental toxicology: adequacy of current methods.
    Peters PW
    Food Addit Contam; 1998; 15 Suppl():55-62. PubMed ID: 9602913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.